Asthma & COPD 2017

Holiday Inn Kensington, London UK (March, 29 - 30, 2017)

Aimed at senior scientists and respiratory and inhalation specialists, Asthma & COPD 2017 will reflect on the ongoing issues and latest developments of these two diseases. 

With a carefully selected panel of industry experts, the 2017 event will address the latest challenges and changes in the fields of asthma and COPD. The agenda will explore ongoing issues, cutting edge developments and novel approaches to treatment surrounding key areas such as biomarkers and targeted treatment, device development and drug delivery. Furthermore the event will deepen understanding of the problems relating to these diseases, and discuss the hot topic of electronic health monitoring.

Hear from MHRA, Mylan, AstraZeneca, Teva UK, GlaxoSmithKline, Boehringer Ingelheim, Glenmark Pharmaceuticals, Janssen, AstraZeneca, Novartis and many more…

Early birds available.

For details or to register, visit the website at www.asthma-copd.co.uk/gate2biotech or contact the team at +44(0) 207827 6000, email zgale@smi-online.co.uk